MedTrace Logo

Efficacy and Cost Effectiveness of Relaxation and Response to CHF

NCT00012818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-04-07

No results posted yet for this study

Summary

Despite the development of significant pharmaceutical treatments, morbidity and mortality of chronic heart failure (CHF) patients remain high, patients� quality of life is poor, and their health care utilization is heavy. It is therefore important to find a cost effective non-pharmaceutical treatment to help CHF patients manage the disease. The relaxation response has been found to be effective in managing CHF-related conditions. With its favorable physiological changes, the relaxation response is likely to benefit CHF patients.

Conditions

Interventions

BEHAVIORAL

relaxation technique

BEHAVIORAL

educational program

Sponsors & Collaborators

Principal Investigators

  • Ann M. Hendricks, PhD · Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA

  • Bei-Hung Chang, ScD · Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2003-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00012818 on ClinicalTrials.gov